ADVERSE OUTCOMES OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AT GASTROENTEROLOGY & HEPATOLOGY CENTERS IN SULAYMANIYAH AND DUHOK CITY

Volume 13 , Issue 1 , March 2023 , Pages 39-48

Authors

Hoshman Rahman Asaad 1 ; Muhsin Abubakr Mohammed 2 ; Ali A. Ramadhan 3 ; Heero Ismael Faraj 2 ; Mohammed Omar Mohammed 4 ; Dana Taib Gharib 3 ; Jutyar Aziz Husain 1 ; Ari Zuhair Sdiq 1

1 Kurdistan Board Trainee, Ministry of Health, Sulaimani, Kurdistan Region, Iraq.

2 Kurdistan Center for Gastroenterology and Hepatology, Sulaimani, Kurdistan Region, Iraq.

3 Azadi Center for Gastroenterology and Hepatology, Duhok, Kurdistan Region, Iraq.

4 College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.

DOI logo 10.17656/jsmc.10395

Keywords

Abstract


Background
Endoscopic retrograde cholangiopancreatography (ERCP) has a significant and managing management of
pancreaticobiliary diseases in Iraq and Kurdistan. Evaluating ERCP adverse outcomes is essential in raising
the effectiveness and safety of ERCP.
Objectives
To review and measure the rate of ERCP complications in our centre and compare our results with other
countries.
Patients and Methods
The present study was a prospective cross-sectional study carried out in the Kurdistan Center of Gastroenterology
and Hepatology (KCGH) in Sulaimani city and Azadi Gastroenterology and Hepatology Center in Duhok city,
Kurdistan region-Iraq through the period of one year from 1st of November 2020, to 31st of October, 2021 on
a sample of two hundred patients underwent ERCP; 140 patients from Sulaimani city and 60 patients from
Duhok city. The researcher followed up with the patients one month after completing ERCP through direct
interviews or by phone calling to observe any ERCP adverse outcomes.
Results
The most typical indication for ERCP among studied patients was choledocholithiasis (43.7%), followed by;
stent removal with occlusion cholangiography (12%) and biliary malignancy (11.6%). The commonest findings
of ERCP among studied patients were bile duct dilation (42.3%), filling defects (33.8%) and bile duct strictures
(14.7%). The post-ERCP complications were present in 45 (22.5%) patients, including pancreatitis (12.5%),
cholangitis (4.5%), hypoxia (3.5%), bleeding (1.5%), perforation (1.5%) and death (0.5%).
Conclusion
The adverse outcomes of ERCP in KCGH in Sulaimani City and the Gastroenterology and Hepatology centre
in Duhok city are increased in the last year..

Statistics
  • Article view777
  • Downloads1
  • Published at21 March 2023

  • RIS
  • BibTeX
  • EndNote
  • Mendeley
  • APA (7th edition)
  • MLA (9th edition)
  • Chicago
  • Harvard
  • IEEE
  • Vancouver